Literature DB >> 12497634

ATM mutations on distinct SNP and STR haplotypes in ataxia-telangiectasia patients of differing ethnicities reveal ancestral founder effects.

Catarina Campbell1, Midori Mitui, Laura Eng, Gabriela Coutinho, Yvonne Thorstenson, Richard A Gatti.   

Abstract

Due to the large size (150 kb) of the ataxia-telangiectasia mutated (ATM) gene and the existence of over 400 mutations, identifying mutations in patients with ataxia-telangiectasia (A-T) is labor intensive. We compared the SNP and STR haplotypes of A-T patients from varying ethnicities who were carrying common ATM mutations. We used SSCP to determine SNP haplotypes. To our surprise, all of the most common ATM mutations in our large multiethnic cohort were associated with specific SNP haplotypes, whereas the STR haplotypes varied, suggesting that ATM mutations predated STR haplotypes but not SNP haplotypes. We conclude that these frequently observed ATM mutations are not hot spots, but have occurred only once and spread with time to different ethnic populations. More generally, a combination of SNP and STR haplotyping could be used as a screening strategy for identifying mutations in other large genes by first determining the ancestral SNP and STR haplotypes in order to identify specific founder mutations. We estimate this approach will identify approximately 30% of mutations in A-T patients across all ethnic groups. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12497634     DOI: 10.1002/humu.10156

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

1.  Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.

Authors:  Kotoka Nakamura; Liutao Du; Rashmi Tunuguntla; Francesca Fike; Simona Cavalieri; Tomohiro Morio; Shuki Mizutani; Alfredo Brusco; Richard A Gatti
Journal:  Hum Mutat       Date:  2011-11-09       Impact factor: 4.878

2.  Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation.

Authors:  Ana B Rodríguez-Martínez; Miguel A Alfonso-Sánchez; José A Peña; Raquel Sánchez-Valle; Inga Zerr; Sabina Capellari; Miguel Calero; Juan J Zarranz; Marian M de Pancorbo
Journal:  Neurogenetics       Date:  2008-03-18       Impact factor: 2.660

Review 3.  New autosomal recessive cerebellar ataxias with oculomotor apraxia.

Authors:  Isabelle Le Ber; Alexis Brice; Alexandra Dürr
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

4.  ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype.

Authors:  Mahnoush Babaei; Midori Mitui; Eric R Olson; Richard A Gatti
Journal:  Hum Genet       Date:  2005-04-21       Impact factor: 4.132

5.  Ataxia telangiectasia-mutated dependent DNA damage checkpoint functions regulate gene expression in human fibroblasts.

Authors:  Tong Zhou; Jeff Chou; Yingchun Zhou; Dennis A Simpson; Feng Cao; Pierre R Bushel; Richard S Paules; William K Kaufmann
Journal:  Mol Cancer Res       Date:  2007-08       Impact factor: 5.852

6.  Identification of ATM mutations in Korean siblings with ataxia-telangiectasia.

Authors:  Hee Jae Huh; Kyoo-Ho Cho; Ji Eun Lee; Min-Jung Kwon; Chang-Seok Ki; Phil Hyu Lee
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

7.  A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian Susceptibility to Mycobacterial Diseases in European descendants.

Authors:  J Yancoski; C Rocco; A Bernasconi; M Oleastro; L Bezrodnik; C Vrátnica; F Haerynck; S D Rosenzweig
Journal:  Infect Genet Evol       Date:  2009-03-09       Impact factor: 3.342

8.  Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.

Authors:  Andrea Prodosmo; Amelia Buffone; Manlio Mattioni; Agnese Barnabei; Agnese Persichetti; Aurora De Leo; Marialuisa Appetecchia; Arianna Nicolussi; Anna Coppa; Salvatore Sciacchitano; Carolina Giordano; Paola Pinnarò; Giuseppe Sanguineti; Lidia Strigari; Gabriele Alessandrini; Francesco Facciolo; Maurizio Cosimelli; Gian Luca Grazi; Giacomo Corrado; Enrico Vizza; Giuseppe Giannini; Silvia Soddu
Journal:  J Exp Clin Cancer Res       Date:  2016-09-06

9.  ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.

Authors:  J L Bernstein; L Bernstein; W D Thompson; C F Lynch; K E Malone; S L Teitelbaum; J H Olsen; H Anton-Culver; J D Boice; B S Rosenstein; A-L Børresen-Dale; R A Gatti; P Concannon; R W Haile
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

10.  A-TWinnipeg: Pathogenesis of rare ATM missense mutation c.6200C>A with decreased protein expression and downstream signaling, early-onset dystonia, cancer, and life-threatening radiotoxicity.

Authors:  Kotoka Nakamura; Francesca Fike; Sara Haghayegh; Rachel Saunders-Pullman; Angelika J Dawson; Thilo Dörk; Richard A Gatti
Journal:  Mol Genet Genomic Med       Date:  2014-03-13       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.